The GFE launched the first Diagnostic System, autoX, specifically developped for blood screening purposes in 2010.
The NAT testing solution from GFE has become the day to day routine test method for approximately 50% of the German blood bank market. Their high quality, robustness and sensitivity is a major pillar for patient safety. Meanwhile more than 16 million blood donations have been tested for viral nucleic acids with this system.
One of the major risk factors in the routine blood testing are mutations in viruses, in partiuclar within the binding region of the PCR primers, which may make them “invisible” to the test system.
The GFE continued to close the detection risk along the polymorphisms of the HIV genome by launching an HIV multiplex assay based on the amplification of three independent target regions.
Staying on top
Climate changes, travelling, or the transfer of viruses from animal to human continuously challenge the local blood screening laboratories.
Not just does it bring viruses of different genotypes into all regions of the world, it also increases the spreading of the natural vectors of some viruses (e.g. mosquitoes).
The GFE continuously monitors this trends and addresses emerging Transfusion Transmitted Infections (TTI) such as e.g. West Nile Virus with the development or adjustment of kits.